Floriva-F 50 mcg+100 mcg (Inhalation Capsule)
Medicine Details
Category | Details |
---|---|
Generic | Salmeterol fluticasone propionate |
Company | Opsonin pharma ltd |
Also available as |
Title
Floriva-F Inhaler
Categories
- Asthma Medication
- Respiratory Therapy
Description
Floriva-F Inhaler is indicated for the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate. The pharmacology includes selective, long-acting beta-2 agonist (Salmeterol Xinafoate) and a corticosteroid with mainly glucocorticoid activity (Fluticasone Propionate). It offers a more convenient regime for patients on concurrent β-agonist and inhaled corticosteroid therapy.
Color Options
- White
Dimensions
- Inhaler: Varies based on dosage strength
- Maxhaler: Varies based on dosage strength
Formulation
Inhalation capsule, Inhaler, Maxhaler
Dosage
- Adults and adolescents 12 years and older: 2 puffs twice daily
- Children (4-12 years): 2 puffs twice daily
Materials
- Plastic
- Metal
Dosage Capsules Available
- 25µg Salmeterol & 50µg Fluticasone
- 25µg Salmeterol & 125µg Fluticasone
- 25µg Salmeterol & 250µg Fluticasone
Age Range
- Adults
- Adolescents (12 years and older)
- Children (4-12 years)
Indication
Treatment of asthma
Mode of Action
- Selective long-acting (12-hour) beta-2-adrenoceptor agonist
- Potent glucocorticoid anti-inflammatory action within the lungs
Usability Features
- Patient friendly
- Ready to use
- Easy to grip
Administration Steps
- Take off the cap
- Shake the inhaler vigorously before each use
- Breathe out fully and hold the inhaler upright
- Release medicine while breathing deeply and slowly through the mouth
- Continue holding breath for at least 10 seconds
- Replace the cap on the mouthpiece after use
- Rinse mouth with water after each treatment
- Check technique in front of a mirror from time to time
Cleaning Instructions
Clean the inhaler at least once a week. Rinse the plastic actuator and cap in warm water without putting the metal canister into water. Dry thoroughly and gently replace the metal canister into the actuator with a twisting motion. Put the cap on the mouthpiece.
Interaction
Avoid non-selective and selective β-blockers in patients with asthma
Contraindications
- Hypersensitivity to salmeterol xinafoate or fluticasone propionate
- Primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required
Side Effects
- Tremor
- Headache
- Cardiac arrhythmia
- Hypersensitivity reactions
- Oropharyngeal irritation
- Muscle cramps
- Hoarseness
- Candidiasis
- Cutaneous hypersensitivity reactions
- Oropharyngeal edema
Pregnancy & Lactation
Use during pregnancy and lactation should be considered if the expected benefit to the mother is greater than any possible risk to the fetus or child
Precautions & Warnings
- Not to be initiated during an exacerbation of asthma
- Not for relief of acute symptoms
- Serious asthma-related adverse events and exacerbations may occur
- Vigilance for the possible development of pneumonia in COPD patients
- Monitoring of growth velocity in pediatric patients
Overdose Effects
- Salmeterol: Seizures, angina, tachycardia, tremor, nausea
- Fluticasone Propionate: Temporary suppression of adrenal function, may lead to adrenal suppression
Therapeutic Class
Long-acting selective β-adrenoceptor stimulants, Respiratory corticosteroids
Storage Conditions
Pressurised canister, Store below 30°C, Keep away from eyes and children
Related Brands
- Aroflo (25 mcg+125 mcg)/puff (Inhaler) - aristopharma-ltd
- Aroflo (25 mcg+250 mcg)/puff (Inhaler) - aristopharma-ltd
- Arotide (25 mcg+125 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
- Arotide (25 mcg+250 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
- Bexitrol F (25 mcg+50 mcg)/puff (Inhaler) - beximco-pharmaceuticals-ltd